Post-thrombotic syndrome future or investigational therapies

Post-thrombotic syndrome Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Post-thrombotic syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Social Impact
Case Studies
Case #1
Post-thrombotic syndrome future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Post-thrombotic syndrome future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Post-thrombotic syndrome future or investigational therapies
CDC on Post-thrombotic syndrome future or investigational therapies
Post-thrombotic syndrome future or investigational therapies in the news
Blogs on Post-thrombotic syndrome future or investigational therapies
Directions to Hospitals Treating Post-thrombotic syndrome
Risk calculators and risk factors for Post-thrombotic syndrome future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Future or Investigational Therapies

The field of PTS still holds many unanswered questions that are important targets for more research. Those include

• fully defining the pathophysiology of PTS, including the role of inflammation and residual thrombus after completion of an appropriate duration of anticoagulant therapy
• developing a PTS risk prediction model
• role of thrombolysis ("clot-busting" drugs) in PTS prevention
• defining the true efficacy of elastic compression stockings for PTS prevention (and if effective, elucidating the minimum compression strength necessary and the optimal timing and duration of compression therapy)
• whether PTS prevention methods are necessary for patients with asymptomatic or distal DVT
• additional treatment options for PTS with demonstrated safety and efficacy (compression and pharmacologic therapies)